Biochemical and molecular properties of the cytochrome P450 arachidonic acid monooxygenases

Prostaglandins and Other Lipid Mediators

Volumn 68-69, Issue , 2002, Pages 325-344

  Capdevila, Jorge H ^a   Falck, John R ^b  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Arachidonic acid bioactivation; Cytochrome P450; Physiological role

Indexed keywords

ALIPHATIC DICARBOXYLIC ACID; ARACHIDONIC ACID; CYTOCHROME P450; OXYGEN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; UNSPECIFIC MONOOXYGENASE; ARACHIDONIC ACID DERIVATIVE; ICOSANOID; ISOENZYME; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; OXYGENASE;

ARTICLE; BIOCHEMISTRY; BIOSYNTHESIS; ENZYME METABOLISM; ENZYMOLOGY; MOLECULAR BIOLOGY; NONHUMAN; OXIDATION REDUCTION REACTION; PHYSIOLOGY; ANIMAL; CHEMISTRY; ENZYME SPECIFICITY; GENETICS; HUMAN; METABOLISM; REVIEW;

ANIMALS; ARACHIDONIC ACIDS; CYTOCHROME P-450 ENZYME SYSTEM; EICOSANOIDS; HUMANS; ISOENZYMES; NADP; OXYGENASES; SUBSTRATE SPECIFICITY;

EID: 18344400259     PISSN: 00906980     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-6980(02)00038-2     Document Type: Article

References (91)

1. McGiff J.C., Quilley J. 20-HETE and the kidney: resolution of old problems and new beginnings. Am. J. Physiol. 277:1999;R607. and references therein.
2. Campbell W.B., Harder D.R. Endothelium-derived hyperpolarizing factors and vascular cytochrome P450 metabolites of arachidonic acid in the regulation of tone. Circ. Res. 84:1999;484. and references therein.
3. Capdevila J.H., Falck J.R., Harris R.C. Cytochrome P450 and arachidonic acid bioactivation: molecular and functional properties of the arachidonate monooxygenase. J. Lipid Res. 41:2000;163. and references therein.
4. Carroll M.A., McGiff J.C. A new class of lipid mediators: cytochrome P450 arachidonate metabolites. Thorax. 55:2000;S13. and references therein.
5. Imig J.D. Eicosanoid regulation of the renal vasculature. Am. J. Physiol. 279:2000;F965. and references therein.
6. Maier K.G., Roman R.J. Cytochrome P450 metabolites of arachidonic acid in the control of renal function. Curr. Opin. Nephrol. Hypertens. 10:2001;81. and references therein.
7. An updated listing of P450 genes, sequences, and activities can be found in the internet at www.dnelson@utmem1.utmem.edu.
8. Waxman DJ, Chang TKH. Hormonal regulation of liver cytochrome P450 enzymes. In: Ortiz de Montellano PR, editor. Cytochrome P450: Structure, Mechanism, and Biochemistry. 2nd Ed. New York: Plenum Press, 1995. p. 391, and references therein.
9. Waxman D.J. P450 gene induction by structurally diverse xenochemicals: central role of nuclear receptors CAR PXR and PPAR. Arch. Biochem. Biophys. 369:1999;11. and references therein.
10. Johnson E.F., Palmer C.A.N., Griffin K.J., Mei-Hui H. Role of the peroxisome-activated receptor in cytochrome P450 4A gene regulation. FASEB. 10:1996;1241. and references therein.
11. Lund J., Zaphiropoulos P.G., Mode A., Warner M., Gustafsson J.A. Hormonal regulation of cytochrome P450 gene expression. Adv. Pharmacol. 22:1991;325. and references therein.
12. Ortiz de Montellano PR, editor. Cytochrome P450: Structure, Mechanism, and Biochemistry. 2nd Ed. Oxygen Activation and Reactivity. New York: Plenum Press, 1995. p. 245, and references therein.
13. White R.E., Coon M.G. Oxygen activation by cytochrome P-450. Annu. Rev. Biochem. 49:1980;315. and references therein.
14. Groves JT, Han Y-Z. Models and mechanisms of cytochrome P450 action. In: Ortiz de Montellano PR, editor. Cytochrome P450: Structure, Mechanism, and Biochemistry. 2nd Ed. New York: Plenum Press, 1995. p. 3, and references therein.
15. Oliw E.H. bis-Allylic hydroxylation of linoleic acid and arachidonic acid by human hepatic 7 monooxygenases. Biochim. Biophys. Acta. 1166:1993;258.
16. Brash A.R., Boeglin W.E., Capdevila J.H., Yeola S., Blair I.A. 7-HETE, 10-HETE, and 13-HETE are major products of NADPH-dependent arachidonic acid metabolism in rat liver microsomes: analysis of their stereochemistry and the stereochemistry of their acid-catalyzed rearrangement. Arch. Biochem. Biophys. 321:1995;485.
17. Capdevila J.H., Yadagiri P., Manna S., Falck J.R. Absolute configuration of the hydroxyeicosatetraenoic acids (HETEs) formed during catalytic oxygenation of arachidonic acid by microsomal cytochrome P-450. Biochem. Biophys. Res. Commun. 141:1986;1007.
18. Woollard P.M. Stereochemical differences between 12-hydroxy-5,8,10,14-eicosatetraenoic acid in platelets and psoriatic lesions. Biochem. Biophys. Res. Commun. 136:1986;169.
19. +-ATPase in the cornea. Proc. Natl. Acad. Sci. U.S.A. 84:1987;8125.
20. Boeglin W.E., Kim R.B., Brash A.R. A 12R-lipoxygenase in human skin: mechanistic evidence, molecular cloning, and expression. Proc. Natl. Acad. Sci. U.S.A. 95:1998;6744.
21. Sun D., McDonnel M., Chen X.S.et al. Human 12(R)-lipoxygenase and the mouse ortholog molecular cloning, expression, and gene chromosomal assignment. J. Biol. Chem. 273:1998;33540.
22. Oliw E.H. Biosynthesis of 12(S)-hydroxyeicosatetraenoic acid by bovine corneal epithelium. Acta Physiol. Scand. 147:1993;117.
23. Murphy R.C., Falck J.R., Lumin S.et al. 12(R)-Hydroxyeicosatrienoic acid: a vasodilator cytochrome P-450-dependent arachidonate metabolite from bovine corneal epithelium. J. Biol. Chem. 263:1988;17197.
24. Lu A.Y., Junk H.K., Coon M.J. Resolution of the cytochrome P-450 containing ω-hydroxylation system of liver microsomes into three components. J. Biol. Chem. 244:1969;3714.
25. Kupfer, D. Endogenous substrates of monooxygenases: fatty acids and prostaglandins. In: Schenkman JB, Kupfer D, editors. Hepatic Cytochrome P-450 Monooxygenase System. New York: Pergamon Press, 1982. p. 157.
26. Sharma R.K., Doig M.V., Lewis D.F.V., Gibson G. Role of hepatic and renal cytochrome P450 IVA1 in the metabolism of lipid substrates. Biochem. Pharmacol. 38:1989;3621.
27. Imaoka S., Tanaka S., Funae Y. (-1)-Hydroxylation of lauric acid and arachidonic acid by rat renal cytochrome P-450. Biochem. Int. 18:1989;731.
28. Johnson E.F., Walker D.L., Griffin K.J. Cloning and expression of three rabbit kidney cDNAs encoding lauric acid-hydroxylases. Biochemistry. 29:1990;873.
29. kd which shows a fatty acid-hydroxylating activity. Eur. J. Biochem. 196:1991;531.
30. Sawamura A., Kusunose E., Satouchi K., Kusunose M. Catalytic properties of rabbit kidney fatty acid-hydroxylase cytochrome P-450ka2 (CYP4A7). Biochim. Biophys. Acta. 1168:1993;30.
31. Imaoka S., Ogawa H., Kimura S., Gonzalez F.J. Complete cDNA sequence and cDNA-directed expression of CYP4A11, a fatty acid omega-hydroxylase expressed in human kidney. DNA Cell Biol. 12:1993;893.
32. Helvig C., Dishman E., Capdevila J.H. Molecular enzymatic and regulatory characterization of rat kidney cytochromes P450 4A2 and 4A3. Biochemistry. 37:1998;12546.
33. Capdevila J.H., Wei S., Helvig C., Falck J.R., Belosludtsev Y., Truan G.et al. The highly stereosepective oxidation of polyunsaturated fatty acids by cytochrome P450 BM3. J. Biol. Chem. 271:1996;22663.
34. Graham-Lorence S., Truan G., Peterson J.A., Falck J.R., Wei S., Helvig C.et al. An active site substitution, F87V, converts cytochrome P450 BM3 into a regio- and stereoselective 14(S),15(R)-AA epoxygenase. J. Biol. Chem. 272:1997;1127.
35. Yokotani N., Bernhardt R., Sogawa K.et al. Two forms of hydroxylase toward prostaglandin A and laurate cDNA cloning and their expression. J. Biol. Chem. 264:1989;21665.
36. Roman L.J., Palmer C.N.A., Clark J.E.et al. Expression of rabbit cytochrome P4504A which catalyzes the hydroxylation of fatty acids, and prostaglandins. Arch. Biochem. Biophys. 307:1993;57.
37. Imaoka S., Nagashima K., Funae Y. Characterization of three cytochrome P450s purified from renal microsomes of untreated male rats and comparison with human renal cytochrome P450. Arch. Biochem. Biophys. 276:1990;473.
38. Stromsteadt M., Hayashi S., Zaphiropoulos P.G., Gustafsson J.A. Cloning and characterization of a novel member of the cytochrome P450 subfamily IVA in rat prostate. DNA Cell Biol. 8:1990;569.
39. 2-terminal amino acid sequences of human and rat kidney fatty acid hydroxylases. Biochem. Biophys. Acta. 1123:1992;156.
40. Palmer C.N.A., Richardson J.H., Griffin K.J.et al. Characterization of a cDNA encoding a human kidney cytochrome P-450 4A fatty acid-hydroxylase and the cognate enzyme expressed in Escherichia coli. Biochim. Biophys. Acta. 1172:1993;61.
41. Johnson E.F., Palmer C.A.N., Griffin K.J., Mei-Hui H. Role of the peroxisome-activated receptor in cytochrome P450 4A gene regulation. FASEB J. 10:1996;1241. and references therein.
42. Waxman D.J. P450 gene induction by structurally diverse xenochemicals: central role of nuclear receptors CAR PXR and PPAR. Arch. Biochem. Biophys. 369:1999;11.
43. Heng Y.M., Kuo S., Jones P.S., Savory R., Schultz R.M., Tomlinson S.R.et al. A novel murine gene Cyp4a14, is part of a cluster of Cyp4a and 4b, but not Cyp4F genes in mouse and humans. Biochem. J. 325:1997;741.
44. Kimura S., Hanioka N., Matsunaga E., Gonzalez F.J. The rat clofibrate-inducible CYP4A gene subfamily I. Complete intron and exon sequence of the CYP4A1 and CYP4A2 genes, unique exon organization and identification of a conserved 19-bp upstream element. DNA. 8:1989;503.
45. Kawashima H., Naganuma T., Kusunose E., Kono T., Yasumoto R., Sugimura K.et al. Human fatty acid ω-hydroxylase CYP4A11: determination of complete genomic sequence and characterization of purified recombinant protein. Arch. Biochem. Biophys. 378:2000;333.
46. Nguyen X., Wang M.-H., Reddy K.M., Falck J.R., Schwartzman M.L. Kinetic profile of the rat CYP4A isoforms: arachidonic acid metabolism and isoform specific inhibitors. Am. J. Physiol. 276:1999;R1691.
47. Hoch U., Zhang Z., Kroetz D.L., Ortiz de Montellano P.R. Structural determination of the substrate specificities and regioselectivities of the rat and human fatty acid omega-hydroxylases. Arch. Biochem. Biophys. 373:2000;63. and references therein.
48. Wang M.H., Stec D.E., Balazy M.et al. Cloning sequencing and cDNA-directed expression of rat renal CYP4A2: arachidonic acid-hydroxylation and 11,12-epoxidation by CYP4A2 protein. Arch. Biochem. Biophys. 336:1997;240.
49. Lasker J.M., Chen B.W., Wolf I., Bloswck B.P., Wilson P.D., Powell P.K. Formation of 20-hydroxyeicosatetraenoic acid, a vasoactive and natriuretic eicosanoid, in human kidney. J. Biol. Chem. 275:2000;4118.
50. Falck J.R., Lumin S., Blair I.et al. Cytochrome P-450-dependent oxidation of arachidonic acid to 16-, 17-, and 18-hydroxyeicosatetraenoic acids. J. Biol. Chem. 265:1990;10244.
51. Rifkind A.B., Kanetoshi A., Orlinick J., Capdevila J.H., Lee C. Purification and biochemical characterization of two major cytochrome P-450 isoforms induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin in chick embryo liver. J. Biol. Chem. 269:1994;3387.
52. 4 20-hydroxylase. J. Biol. Chem. 262:1987;2421.
53. Kikuta Y., Kusunose E., Endo K.et al. A novel form of cytochrome P-450 family 4 in human polymorphonuclear leukocytes. J. Biol. Chem. 268:1993;9376.
54. Kikuta Y., Kusunose E., Kusunose M. Purification and characterization of recombinant rat hepatic CYP4F1. Arch. Biochem. Biophys. 369:1999;193.
55. Christmas P., Ursino S.R., Fox J.W., Soberman R.J. Expression of the CYP43 gene. Tissue-specific splicing and alternative promoters generate high and low K(m) forms of leukotriene B(4) omega-hydroxylase. J. Biol. Chem. 274:1999;21191.
56. Bylund J., Hidestrand M., Ingelman-Sundberg M., Oliw E.H. Identification of CYP4F8 in human seminal vesicles as a prominent 19-hydroxylase of prostaglandin endoperoxides. J. Biol. Chem. 275:2000;21844.
57. Laethem R.M., Balazy M., Falck J.R., Laethem C.L., Koop D.R. Formation of 19(S)-, 19(R)-, and 18(R)-hydroxyeicosatetraenoic acids by alcohol-inducible cytochrome 450 2E1. J. Biol. Chem. 268:1993;12912.
58. Wu S., Chen W., Murphy E., Gabel S., Tomer K.B., Foley J.et al. Molecular cloning, expression, and functional significance of a cytochrome P450 highly expressed in rat heart myocytes. J. Biol. Chem. 272:1997;2551.
59. Wu S., Moomaw C.R., Tomer K.B., Falck J.R., Zeldin D.C. Molecular cloning and expression of CYP2J2, a human cytochrome P450 arachidonic acid epoxygenase highly expressed in heart. J. Biol. Chem. 271:1996;3460.
60. Qu W., Bradbury A., Tsao C., Marapont R., Harry J.G., Parker C.E.et al. Cytochrome P450 CYP2J9 a new mouse arachidonic acid ω-1 hydroxylase predominantly expressed in brain. J. Biol. Chem. 276:2001;25467.
61. Ito O., Alonso-Galicia M., Hopp K., Roman R.J. Localization of cytochrome P-450 isoforms along the rat nephron. Am. J. Physiol. 274:1998;F395.
62. 2. J. Biol. Chem. 276:2001;15704.
63. Hashimoto T., Fujita T., Usuda N.et al. Peroxisomal and mitochondrial fatty acid-oxidation in mice nullizygous for both peroxisomal proliferator activated receptor and peroxisomal fatty acyl-CoA oxidase. J. Biol. Chem. 274:1999;19228.
64. Oliw E.H., Oates J.A. Oxygenation of AA by hepatic microsomes of the rabbit. Mechanism of biosynthesis of two vicinal diols. Biochim. Biophys. Acta. 666:1981;327.
65. Chacos N., Falck J.R., Wixtrom C., Capdevila J. Novel epoxides formed during the liver cytochrome P-450 oxidation of AA. Biochem. Biophys. Res. Commun. 104:1982;916.
66. Karara A., Dishman E., Blair I., Falck J.R., Capdevila J.H. Endogenous epoxyeicosatrienoic acids. Cytochrome P-450 controlled stereoselectivity of the hepatic arachidonic acid epoxygenase. J. Biol. Chem. 264:1989;19822.
67. Fang X., Kaduce T.L., Weintraub N.L., Harmon S., Teesch L.M., Morisseau C.et al. Pathways of epoxyeicosatrienoic acid metabolism in endothelial cells. Implications for the vascular effects of soluble epoxide hydrolase inhibition. J. Biol. Chem. 276:2001;14867.
68. Zeldin D.C., Kobayashi J., Falck J.R.et al. Regio- and enantiofacial selectivity of epoxyeicosatrienoic acid hydration by cytosolic epoxide hydrolase. J. Biol. Chem. 268:1993;640.
69. Spreaman M.E., Prough R.A., Estabrook R.W., Falck J.R., Manna S., Leibman K.C.et al. Novel glutathione conjugates formed from epoxyeicosatrienoic acids (EETs). Arch. Biochem. Biophys. 242:1985;225.
70. Capdevila J.H., Karara A., Waxman D.J., Martin M.V., Falck J.R., Guengerich F.P. Cytochrome P-450 enzyme-specific control of the regio- and enantiofacial selectivity of the microsomal arachidonic acid epoxygenase. J. Biol. Chem. 265:1990;10865.
71. Karara A., Makita K., Jacobson H.R.et al. Molecular cloning, expression, and enzymatic characterization of the rat kidney cytochrome P-450 arachidonic acid epoxygenase. J. Biol. Chem. 268:1993;13565.
72. Capdevila J.H., Wei S., Yan Y.et al. Cytochrome P-450 arachidonic acid epoxygenase. Regulatory control of the renal epoxygenase by dietary salt loading. J. Biol. Chem. 267:1992;21720.
73. Holla V.R., Makita K., Zaphiropoulos P.G., Capdevila J.H. The kidney cytochrome P450 2C23 arachidonic acid epoxygenase is upregulated during dietary salt loading. J. Clin. Invest. 104:1999;751.
74. Daikh B.E., Laethem R.M., Koop D. Stereoselective epoxidation of arachidonic acid by cytochrome P-450s 2carachidonic acid and 2C2. J. Pharmacol. Exp. Ther. 269:1994;1130.
75. Knickle L.C., Bend J.R. Bioactivation of arachidonic acid by the cytochrome P450 monooxygense of guinea pig lung: the orthologue of cytochrome P450 2B4 is solely responsible for the formation of epoxyeicosatrienoic acids. Mol. Pharmacol. 45:1994;1273.
76. Keeney D.S., Skinner C., Wei S., Friedberg T., Waterman M.R. A keratinocyte-specific epoxygenase, CYP2B12, metabolizes arachidonic acid with unsual selectivity, producing a single major epoxyeicosatrienoic acid. J. Biol. Chem. 273:1998;9279.
77. Laethem R.M., Halpert J.R., Koop D.R. Epoxidation of arachidonic acid as an active site probe of cytochrome P450 2B isoforms. Biochim. Biophys. Acta. 1206:1994;42.
78. Imaoka S., Zwedlung P.J., Ogawa H., Kimura S., Gonzalez F.J., Kim H.Y. Identification of CYP2C23 expressed in rat kidney an arachidonic acid epoxygenase. J. Pharamcol. Exp. Ther. 267:1993;1012.
79. Zeldin D.C., DuBois R.N., Falck J.R., Capdevila J.H. Molecular cloning, expression and characterization of an endogenous human cytochrome P450 arachidonic acid epoxygenase isoform. Arch. Biochem. Biophys. 322:1995;76.
80. Luo G., Zeldin D.C., Blaisdell J.A., Hodgson E., Goldstein J.A. Cloning, and expression of murine CYP2Cs and their ability to metabolize arachidonic acid. Arch. Biochem. Biophys. 357:1998;45.
81. Rifkind A.B., Lee C., Chang T.K., Waxman D.J. Arachidonic acid metabolisms by human cytochrome P450s 2C8, 2C9, 2E1, and 1A2: regioselective oxygenation and evidence for a role for CYP2C enzymes in arachidonic acid epoxygenation in human liver microsomes. Arch. Biochem. Biophys. 320:1995;380.
82. Keeney D.S., Skinner C., Travers J.B.et al. Differentiating keratinocytes express a novel cytochrome P450 enzyme, CYP2B19, having arachidonate monooxygenase activity. J. Biol. Chem. 273:1998;32071.
83. Zeldin D.C., Moomaw C.R., Jesse N.et al. Biochemical characterization of the human liver cytochrome P450 arachidonic acid pathway. Arch. Biochem. Biophys. 330:1996;87.
84. Fisslthaler B., Popp R., Kiss L.et al. Cytochrome P450 2C is an EDHF synthase in coronary arteries. Nature. 410:1999;493.
85. Karara A., Dishman E., Falck J.R., Capdevila J.H. Endogenous epoxyeicosatrienoyl-phospholipids. A novel class of cellular glycerolipids containing epoxidized arachidonate moieties. J. Biol. Chem. 266:1991;7561.
86. Brezinski M., Serhan C.N. Selective incorporation of 15(S)-hydroxyeicosatetraenoic acid in phosphatidylinositol of human neutrophils: agonist-induced deacylation and transformation of stored hydroxyeicosanoids. Proc. Natl. Acad. Sci. U.S.A. 87:1990;6248.
87. Legrand A.B., Lawson J.A., Meyrick B.O., Blair I.A., Oates J.A. Substitution of 15-hydroxyeicosatetraenoic acid in the phosphoinositide signaling pathway. J. Biol. Chem. 266:1991;7570.
88. Bernstrom K., Kayganich K., Murphy R.C., Fitzpatrick F.A. Incorporation and distribution of epoxyeicosatrienoic acids into cellular phospholipids. J. Biol. Chem. 267:1992;3686.
89. Capdevila JH, Jin Y, Karara A, Falck JR. Cytochrome P450 epoxygenase dependent formation of novel endogenous epoxyeicosatrienoyl-phospholipids. In: Nigam S, Marnett LJ, Honn KV, Walden Jr TL, editors. Eicosanoids and other Bioactive Lipids in Cancer, Inflammation and Radiation Injury. Boston, MA: Kluwer Academic Publisher, 1993. p. 11.
90. Chen J., Capdevila J.H., Zeldin D.C., Rosenberg R.L. Inhibition of cardiac L-type calcium channels by epoxyeicosatrienoic acids. Mol. Pharmacol. 5:1999;288.
91. Holla V.R., Adas F., Imig J.D., Zhao X., Price E., Olsen N.et al. Alterations in the regulation of androgen sensitive Cyp 4a monooxygenases causes hypertension. Proc. Natl. Acad. Sci. U.S.A. 98:2001;5211.